Molecular pharmaceutics · 2025
Enhancing Sonodynamic Therapy for Cervical Cancer Using Ultrasound-Activated BTO@PEG.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Chengqing, Ding Lu, Chen Shangke, Liu Lu, Zeng Xiang, Yan Qi, Wang Jiabo, Saitiniaz Nazila, Yang Nan, Xu Xiaoya, Mu Yuming, Chen Zhen, Li Rong
Аннотация
Patients with advanced cervical cancer have a poor prognosis, and sonodynamic therapy (SDT) is expected to offer a new approach for improving the therapeutic outcome of cervical cancer due to its noninvasiveness and ability to penetrate deeply into tissues. In order to overcome the problems of the rapid elimination and low water solubility of organic acoustic sensitizers in SDT, DSPE-PEG2000-coated tetragonal-phase barium titanate nanoparticles (BTO@PEG) were employed in this study to replace the conventional nanoacoustic sensitizers. It was found that BTO@PEG could continuously generate ROS through SDT and the piezoelectric effect under ultrasound (US) stimulation, which subsequently promoted the apoptosis of cervical cancer cells and inhibited the growth of subcutaneously transplanted HeLa-derived cervical cancer tumors in nude mice. BTO@PEG showed good biocompatibility, as confirmed by cytology and animal experiments.